Press Release Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA’s 503A Bulks List, Including BPC-157, TB-500 and MOTS-c Jul 28
Press Release Vanta Announces Updated Time for Participation in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET Jul 21